Cyclin D2 抗体
Quick Overview for Cyclin D2 抗体 (ABIN487478)
抗原
See all Cyclin D2 (CCND2) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
特异性
- This antibody reacts with Human and Mouse Cyclin D2.
-
产品特性
- Synonyms: Cyclin-D2, CCND2
-
纯化方法
- Protein-A Sepharose Chromatography.
-
免疫原
- Full-length recombinant Human Cyclin D2 protein. Remarks: Hybridoma was established by fusion of mouse myeloma cell NS-2 with Balb/cmouse splenocyte.
-
亚型
- IgG2a
-
-
anti-Cyclin D2 (CCND2) (AA 161-288) antibody
CCND2 适用: 人, 小鼠, 大鼠 WB, ELISA, FACS, IF (cc), IF (p), IHC (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Cyclin D2 (CCND2) (AA 1-289) antibodyCCND2 适用: 人 WB, ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Cyclin D2 (CCND2) (AA 47-267) antibodyCCND2 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Cyclin D2 (CCND2) (AA 1-289) antibodyCCND2 适用: 人 WB, IF, PLA 宿主: 兔 Polyclonal unconjugated
anti-Cyclin D2 (CCND2) (AA 68-278) antibodyCCND2 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Cyclin D2 (CCND2) (AA 1-289) antibodyCCND2 适用: 人 WB, IP, IF 宿主: 兔 Polyclonal unconjugated
anti-Cyclin D2 (CCND2) (AA 1-289) antibodyCCND2 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Cyclin D2 (CCND2) (AA 215-285) antibodyCCND2 适用: 人 WB, ELISA, IF 宿主: 兔 Polyclonal unconjugated
anti-Cyclin D2 (CCND2) antibodyCCND2 适用: 人 ELISA, Coat 宿主: 小鼠 Monoclonal CCND2-2620 unconjugated
anti-Cyclin D2 (CCND2) (AA 190-289) antibodyCCND2 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 3B10 unconjugated
-
-
应用备注
-
Western blott: 1 μg/mLImmunoprecipitation: 2 μg/200-300 μL of cell extract. Positive Control: NIH/3T3 cells. It is reported that this clone is reactive with several Human cells such as U-2-OS, Bristol-8and Lovo36 (See Reference 1). Detailed procedure is provided in Protocols.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
实验流程
- SDS-PAGE & Western Blotting1) Wash the cells 3 times with PBS and suspend with 10 volume of cold Lysis buffer (50 mMTris-HCl, pH 7. 2, 250 mM NaCl, 0. 1% NP-40, 2 mM EDTA, 10% glycerol) containingappropriate protease inhibitors. Incubate it at 4°C with rotating for 30 minutes, thensonicate briefly (up to 10 seconds). 2) Centrifuge the tube at 12,000 x g for 10 minutes at 4°C and transfer the supernatant toanother tube. Measure the protein concentration of the supernatant and add the Lysisbuffer to make 8 mg/mL solution. 3) Mix the sample with equal volume of Laemmli's sample buffer. 4) Boil the samples for 2 minutes and centrifuge. Load 10 μL of the sample per lane in a 1mm thick SDS-polyacrylamide gel for electrophoresis. 5) Blot the protein to a polyvinylidene difluoride (PVDF) membrane at 1 mA/cm2 for 1 hourin a semi-dry transfer system. (Transfer Buffer: 25 mM Tris, 190 mM glycine, 20% MeOH). See the manufacture's manual for precise transfer procedure. 6) To reduce nonspecific binding, soak the membrane in 10% skimmed milk (in PBS, pH7. 2) for 1 hour at RT, or overnight at 4°C. 7) Incubate the membrane with the anti-cyclin D2 monoclonal antibody (1 μg/mL) dilutedwith 1% skimmed milk (in PBS, pH 7. 2) for 1 hour at RT8) Wash the membrane with PBS (5 min x 6 times). 9) Incubate the membrane with the 1: 10000POD-conjugated anti-mouse IgG diluted with 1% skimmed milk (in PBS, pH 7. 2) for 1 h atRT. 10) Wash the membrane with PBS (5 minutes x 6 times)11) Wipe excess buffer on the membrane, then incubate it with appropriatechemiluminescence reagent for 1 minute. Remove extra reagent from the membrane bydabbing with paper towel, and seal it in plastic wrap. 12) Expose to an X-ray film in a dark room for 5 minutes. Develop the film as usual. Thecondition for exposure and development may vary. Positive Control for Western blotting: NIH/3T3Immunoprecipitation1) Wash the cells 3 times with PBS and suspend with 10 volume of cold Lysis buffer (50 mMTris-HCl pH 7. 2, 250 mM NaCl, 0. 1% NP-40, 2 mM EDTA, 10% glycerol) containingappropriate protease inhibitors. Incubate it at 4°C with rotating for 30 minutes, thensonicate briefly (up to 10 seconds)2) Centrifuge the tube at 12,000 x g for 10 min at 4°C and transfer the supernatant toanother tube. 3) Add 2 μg of the anti-cyclin D2 monoclonal antibody into 250 μL of the supernatant. Mixwell and incubate with gentle agitation for 30-120 minutes at 4°C. Add 20 μL of 50%Protein A-agarose beads resuspended in the Lysis buffer. Mix well and incubate with gentleagitation for 60 min at 4°C. 4) Wash the beads 3-5 times with the ice-cold Lysis buffer (centrifuge the tube at 2,500 x gfor 10 seconds). 5) Resuspend the beads in 20 μL of Laemmli’s sample buffer, boil for 3-5 min, andcentrifuge for 5 minutes. Use 10 μL/lane for the SDS-PAGE analysis. (See SDS-PAGE & Western blotting. )
-
限制
- 仅限研究用
-
-
-
浓度
- 1.0 mg/mL
-
缓冲液
- PBS, pH 7.2 containing 50 % Glycerol without preservatives.
-
储存液
- Without preservative
-
储存条件
- -20 °C
-
储存方法
-
Store the antibody undiluted at -20 °C.
Shelf life: one year from despatch. -
有效期
- 12 months
-
-
- Cyclin D2 (CCND2)
-
别名
- Cyclin D2
-
背景
- Cyclin D2 (34 kDa) is one of three D-type cyclins that are synthesized in G1 phase and induced in response to agents that promote re-entry into the cell cycle. D-type cyclins assemble with cyclin-dependent kinases Cdk4 and Cdk6 to form complexes that phosphorylate key substrates, including the retinoblastoma protein Rb, involved in proliferation. Generally, D cyclins appear late in the G1 phase of the cell cycle, however, cyclin D2 accumulates in Go and at the G1/S interface. A role for cyclin D2 has been suggested in differentiation and oncogenic transformation. Cyclin D2 is expressed in macrophages in response to CSF-1 stimulation, and overexpression of cyclin D2 is associated with increased in vivo invasiveness of human squamous carcinoma cells.Synonyms: CCND2, Cyclin-D2
-
基因ID
- 894
-
UniProt
- P30279
-
途径
- Cell Division Cycle, Mitotic G1-G1/S Phases
抗原
-
